Stay updated on Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has changed from v2.8.0 to v2.8.1, indicating an update or modification to the content of the webpage.
    Difference
    0.0%
    Check dated 2024-06-13T23:30:48.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details of a clinical trial evaluating the efficacy and safety of pembrolizumab plus concurrent chemoradiotherapy compared to placebo plus concurrent chemoradiotherapy in participants with locally advanced cervical cancer.
    Difference
    0.0%
    Check dated 2024-06-06T14:51:43.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change includes examples of eligibility criteria such as a person's general health condition or prior treatments, and provides a link for general information about clinical research.
    Difference
    18%
    Check dated 2024-05-22T21:37:37.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2024-04-30T22:35:03.000Z thumbnail image

Stay in the know with updates to Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.